Novo Nordisk · 11 hours ago
Internship - Government Accountability
Plainsboro, NJ
Internship
Onsite
Intern
$52K/yr - $89K/yrNovo Nordisk is committed to building the best Ethics, Compliance & Privacy team in the pharmaceutical industry. The intern will assist in creating training documentation for state-level reporting laws and support data manipulation for compliance initiatives.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Help with creating training documentation for state level reporting laws
The training will be in PowerPoint form and be housed on the Government Accountability website
Responsible for data manipulation within Excel to support state and federal reporting initiatives including price transparency as well as other state requirements
Responsible for creating work instructions to support any new or existing state or federal requirements
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than April 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate degree in Legal, Compliance, Criminal Justice, Marketing or a related discipline preferred
Class year of a junior or senior preferred
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Founded in 1923
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Leadership Team
Lars Fruergaard Jørgensen
President and CEO
Lars Sorensen
President & CEO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase